About CardioFocus
CardioFocus is a company based in Marlborough (United States) founded in 1990. CardioFocus has raised $260.86 million across 22 funding rounds from investors including Boston Scientific, SVB and HHS. CardioFocus offers products and services including HeartLight X3 and Centauri System. CardioFocus operates in a competitive market with competitors including AtaCor Medical, AtriCure, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardiofocus Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$260.86 M (USD)
in 22 rounds
-
Latest Funding Round
$31.76 M (USD), Series E
Feb 23, 2023
-
Investors
Boston Scientific
& 17 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CardioFocus
CardioFocus offers a comprehensive portfolio of products and services, including HeartLight X3 and Centauri System.
Provides precise laser technology for atrial fibrillation ablation procedures.
Delivers efficient PFA technology for cardiac arrhythmia management.
People of CardioFocus
Unlock access to complete
Funding Insights of CardioFocus
CardioFocus has successfully raised a total of $260.86M across 22 strategic funding rounds. The most recent funding activity was a Series E round of $31.76 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CardioFocus
CardioFocus has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, SVB and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US and Korea
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CardioFocus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CardioFocus
Investment portfolio details for CardioFocus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CardioFocus
Detailed financials for CardioFocus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardiofocus Comparisons
Peer comparison for CardioFocus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CardioFocus
CardioFocus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| Locked | Locked | Locked |
Trans-septal implants for atrial fibrillation treatment are developed.
|
Detailed competitors of CardioFocus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardiofocus
Complete news archive for CardioFocus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioFocus
CardioFocus was founded in 1990 and raised its 1st funding round 10 years after it was founded.
CardioFocus is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
CardioFocus is a funded company, having raised a total of $260.86M across 22 funding rounds to date.
CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.
CardioFocus's top competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies.
CardioFocus offers HeartLight X3 and Centauri System.
CardioFocus has 18 investors. Key investors include Boston Scientific, SVB, HHS, Boston University, and Oxford Finance.